pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Empagliflozin in Patients With Glomerulonephritis
Status: COMPLETED
Conditions: Glomerulonephritis|Proteinuria
Interventions: DRUG: Empagliflozin 25 MG|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress
Status: COMPLETED
Conditions: Anxiety|Stress
Interventions: DIETARY_SUPPLEMENT: PROBIOSTICK® during 30 days|DIETARY_SUPPLEMENT: Placebo during 30 days
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department Visit
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Fluticasone propionate/salmeterol combination ED MD|DRUG: Fluticasone propionate/salmeterol combination OP MD
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction
Status: TERMINATED
Conditions: Suspected Biliary Obstruction
Interventions: PROCEDURE: ERCP|PROCEDURE: MRCP
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Efficacy and Safety of Switching to Vemliver Tab From Entecavir in Chronic Hepatitis B Patients Who Pretreated With Entecavir
Status: ACTIVE_NOT_RECRUITING
Conditions: Hepatitis B, Chronic
Interventions: DRUG: Vemliver tablet|DRUG: Baracross Tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Anticoagulation After GI Bleeding Pilot Study and Registry
Status: RECRUITING
Conditions: GastroIntestinal Bleeding|Anticoagulant-induced Bleeding
Interventions: OTHER: Restart DOAC within 7 days of clinical hemostasis after GI bleeding|OTHER: Restart DOAC between 7 to 14 days of clinical hemostasis after GI bleeding
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effects of Propranolol on Fear of Tooth or Molar Extraction
Status: COMPLETED
Conditions: Dental Anxiety
Interventions: DRUG: Propranolol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Study to Assess the Safety and Efficacy of Mechanochemical Ablation With Flebogrif in Patients With Great Saphenous Vein Insufficiency
Status: COMPLETED
Conditions: Chronic Venous Insufficiency, CVI
Interventions: DEVICE: FLEBOGRIF
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients
Status: COMPLETED
Conditions: Colorectal Neoplasms
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.
Status: COMPLETED
Conditions: Insulin Sensitivity|Polycystic Ovarian Syndrome
Interventions: OTHER: Semi-controlled nutritional intervention with fish protein diet|OTHER: Semi-controlled intervention with other animal proteins
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Measurement of the Skin Sympathetic Nerve Activity
Status: COMPLETED
Conditions: Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery
Interventions: DRUG: Rocuronium
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Evaluation of the Clinical Impact of Ultra Fast-Track in Patients Undergoing Cardiac Surgery
Status: RECRUITING
Conditions: Cardiac Disease|Surgery|Anesthesia
Interventions: BEHAVIORAL: Ultra Fast-track
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Status: COMPLETED
Conditions: Prostatic Neoplasms|Cardiovascular Diseases
Interventions: DRUG: Degarelix (LHRH antagonist)|DRUG: LHRH agonist|DEVICE: EndoPAT2000
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Robotic Gait Training in Spinal Cord Injury
Status: COMPLETED
Conditions: Spinal Cord Injuries
Interventions: DEVICE: 30 minutes Lokomat|DEVICE: 60 minutes Lokomat
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Community Trial of Newborn Vitamin A Supplementation to Reduce Infant Mortality in Rural Bangladesh
Status: COMPLETED
Conditions: Mortality Through Six Months of Age|Vitamin A Deficiency
Interventions: DIETARY_SUPPLEMENT: vitamin A supplementation (15,000 ug retinol equivalents or 50,000 IU)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: PREVENTION
Clinical trial: Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Atypical Hyperplasia|Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia|FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma|FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Interventions: DRUG: Exemestane|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacokinetic Study|OTHER: Questionnaire Administration
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster
Status: RECRUITING
Conditions: Neuropathic Pain
Interventions: DRUG: Vitamin C
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes
Status: COMPLETED
Conditions: Type 2 Diabetes Mellitus
Interventions: DIETARY_SUPPLEMENT: Low-fat Diet|DIETARY_SUPPLEMENT: Low-carbohydrate Diet|DIETARY_SUPPLEMENT: Mediterranean Diet
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
Status: UNKNOWN
Conditions: Atrial Fibrillation
Interventions: DRUG: Dabigatran etexilate|DRUG: Rivaroxaban|DRUG: Apixaban
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents
Status: COMPLETED
Conditions: Infections, Meningococcal
Interventions: BIOLOGICAL: Bexsero|OTHER: Saline Placebo|BIOLOGICAL: Havrix|BIOLOGICAL: MenABCWY
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Effect of Intraoperative Magnesium Infusion on Postoperative Pain and Cognitive Function
Status: UNKNOWN
Conditions: the Effect of Intraoperative Magnesium Infusion on Postoperative Cognitive Functions in Adult Patients After Elective Pelvi-abdominal Surgeries
Interventions: DRUG: Magnesium Sulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC
Status: RECRUITING
Conditions: Small-cell Lung Cancer|Large Cell Neuroendocrine Carcinoma of the Lung|Extrapulmonary Small Cell Carcinoma
Interventions: DRUG: Abemaciclib,
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sub-Q Versus IV Furosemide in Acute Heart Failure
Status: COMPLETED
Conditions: Congestive Heart Failure
Interventions: DRUG: Furosemide Injection Solution (SCP-101)|DRUG: Furosemide Injection Solution, USP
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Does Sweet Taste Potentiate Nicotine Cue Reactivity?
Status: COMPLETED
Conditions: Healthy
Interventions: DEVICE: flavor and sweetener|DEVICE: flavor and nicotine|DEVICE: flavor, nicotine and sweetener|DEVICE: flavor
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Comparison of MAG and Fish Oil Efficacy
Status: COMPLETED
Conditions: Obesity
Interventions: DIETARY_SUPPLEMENT: Fish oil enriched with EPA|DIETARY_SUPPLEMENT: MAG-EPA oil|DRUG: Orlistat
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING
Clinical trial: An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer
Status: COMPLETED
Conditions: Hormone-refractory Prostate Cancer
Interventions: DRUG: Thalidomide (THADO)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effectiveness of Pleuran in Treatment of Acute Gastroenteritis in Children
Status: COMPLETED
Conditions: Diarrhoea;Acute
Interventions: DIETARY_SUPPLEMENT: Imunoglukan PH4|DIETARY_SUPPLEMENT: Placebo (vitamin C syrup)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Levothyroxine Sodium Tablets 200 mg|DRUG: Synthroid Tablets 200 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Budesonide/formoterol|OTHER: Charcoal|DRUG: Symbicort Turbuhaler
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF)
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: DRUG: Docosahexaenoic acid|DRUG: Sunflower Oil
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Prevalence of Port Site Hernia After Mesh Placement in Laparoscopic Cholecystectomy.
Status: COMPLETED
Conditions: Incisional Hernia
Interventions: PROCEDURE: Control|DEVICE: Experimental
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma
Status: COMPLETED
Conditions: Thymoma|Thymic Carcinoma
Interventions: DRUG: carboplatin|DRUG: paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
Status: COMPLETED
Conditions: Epilepsy|Complex Partial Seizures|Epilepsy, Complex Partial|Epilepsies, Partial
Interventions: DRUG: carisbamate
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Changes in Biochemical Markers of Bone Turnover (Serum CTX and PlNP) After Initiation of a "Drug Holiday" From Bisphosphonates
Status: UNKNOWN
Conditions: Osteoporosis
Interventions: OTHER: No intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose:
Clinical trial: VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）
Status: NOT_YET_RECRUITING
Conditions: Aortic Valve Disease|Aortic Valve Stenosis
Interventions: DEVICE: VitaFlow® Transcatheter Aortic Valve Replacement System
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function
Status: ACTIVE_NOT_RECRUITING
Conditions: Acute Myocardial Infarction|Non-ST Elevation Myocardial Infarction|ST Elevation Myocardial Infarction
Interventions: OTHER: Non-betablocker|DRUG: Betablocker
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Slider Versus Tensioner Neural Mobilization in Diabetic Peripheral Neuropathy
Status: COMPLETED
Conditions: Diabetic Peripheral Neuropathic Pain
Interventions: OTHER: Sliding Neural mobilization|OTHER: Tensioner Neural mobilization|OTHER: Stretching exercises|DEVICE: TENS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CPAP for OSA on Myocardial Salvage After pPCI for STEMI Patients
Status: UNKNOWN
Conditions: Obstructive Sleep Apnea|ST Elevation Myocardial Infarction
Interventions: DEVICE: Continuous positive airway pressure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Adjuvant Dexmedetomidine and Tramadol in Subcostal Transversus Abdominis Plan Block
Status: COMPLETED
Conditions: Transversus Abdominis Plane Block
Interventions: PROCEDURE: Dexmedetomidin + bupivacaine|DRUG: Tramadol + Bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING
Clinical trial: Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year
Status: RECRUITING
Conditions: Laryngomalacia|Sleep Apnea, Obstructive|Sleep Apnea|Ear, Nose and Throat Disorder|Pediatric Disorder|Surgery|Quality of Life
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Safety, Virological and Immunological Assessment of Live Attenuated Dengue Serotype 2 rDEN2delta30-7169.
Status: NOT_YET_RECRUITING
Conditions: Dengue
Interventions: BIOLOGICAL: rDEN2Δ30-7169
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Role of Granisetron in Preventing Hypotension After Spinal Anesthesia With Levobupivacaine in Rheumatic Patients Undergoing Elective Cesarean Section
Status: UNKNOWN
Conditions: Granisetron
Interventions: DRUG: Granisetron Hydrochloride|OTHER: 0.9% normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
Status: UNKNOWN
Conditions: Hemochromatosis
Interventions: DRUG: Pantoprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: tDCS, Stress and Risk for Schizophrenia
Status: COMPLETED
Conditions: Schizophrenia
Interventions: DEVICE: Transcranial stimulation in direct current
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)
Status: COMPLETED
Conditions: Myocardial Infarction
Interventions: DRUG: Clopidogrel|DRUG: Ticagrelor 90mg
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Status: RECRUITING
Conditions: Esophagus Cancer|Bladder Cancer|Liver Cancer|Ovarian Cancer|Small-cell Lung Cancer
Interventions: BIOLOGICAL: Intravenous injection of P-IL-2|BIOLOGICAL: P-IL-2 plus Anti-PD-1 Monoclonal Antibody
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer
Status: UNKNOWN
Conditions: Gastric Cancer
Interventions: DRUG: paclitaxel-albumin and S-1
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Optimal Exercise Frequency to Reduce Liver Fat in Centrally Obese Adults With Non-Alcoholic Fatty Liver Disease
Status: RECRUITING
Conditions: Non-Alcoholic Fatty Liver Disease|Obesity
Interventions: BEHAVIORAL: Once-a-week Exercise|BEHAVIORAL: Thrice-a-week Exercise|OTHER: Usual Care Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer
Status: RECRUITING
Conditions: Advanced Breast Cancer
Interventions: DRUG: Eribulin Mesylate + Samfenet (Trastruzumab-biosimilar)|DRUG: Eribulin Mesylate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Telephone Counseling and the Distribution of Nicotine Patches to Smokers
Status: COMPLETED
Conditions: Smoking Cessation
Interventions: DRUG: Nicotine Patch|BEHAVIORAL: Telephone Counseling|DRUG: Placebo|OTHER: Self-Help Materials
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Beta-blocker Administration for Cardiomyocyte Division
Status: RECRUITING
Conditions: Tetralogy of Fallot|Double Outlet Right Ventricle
Interventions: OTHER: N-thymidine|OTHER: Urine Collection|PROCEDURE: Echocardiogram|PROCEDURE: Cardiac MRI|DRUG: Propranolol Hydrochloride|DRUG: Placebo|PROCEDURE: Physical Exam|OTHER: Specimen Collection
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Heartrate and Breathing Effects on Attention and Memory
Status: NOT_YET_RECRUITING
Conditions: Age-related Cognitive Decline|Alzheimer Disease
Interventions: BEHAVIORAL: Daily practice
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: The SToICAL Study - The Soft Tissue Injection of Corticosteroid And Local Anaesthetic Study
Status: UNKNOWN
Conditions: Carpal Tunnel Syndrome|De Quervains Tenosynovitis|Trigger Finger
Interventions: DRUG: 1ml of triamcinolone (40mg/1ml)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: EffectivenesS of Additional X-ray PRotection dEviceS in Reducing Scattered Radiation in Radial interventiOn
Status: COMPLETED
Conditions: Exposure of Member of Staff to Medical Diagnostic X-Ray
Interventions: RADIATION: Plain X-ray protection shield|RADIATION: Protection shield & X-ray protective strips|RADIATION: Protection shield & protective strips & patient cut-outs
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
Status: COMPLETED
Conditions: HIV|Cardiovascular Disease
Interventions: DRUG: Rosuvastatin|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Walnut Oral Immunotherapy for Tree Nut Allergy
Status: WITHDRAWN
Conditions: Peanut Allergy
Interventions: DRUG: walnut powder|DRUG: walnut powder
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Art Therapy on Reducing Pain and Anxiety in Children Receiving Venipuncture
Status: COMPLETED
Conditions: Venipuncture|Pain|Anxiety|Fear
Interventions: OTHER: Trace Image and Coloring for Kids-Book (TICK-B)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Status: WITHDRAWN
Conditions: Coronary Artery Disease
Interventions: DRUG: Asprin|DRUG: Clopidogrel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
Status: COMPLETED
Conditions: 22q11 Deletion Syndrome|DiGeorge Syndrome|Trisomy 21|Trisomy 18|Trisomy 13|Monosomy X|Sex Chromosome Abnormalities|Cri-du-Chat Syndrome|Angelman Syndrome|Prader-Willi Syndrome|1p36 Deletion Syndrome
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Investigation of the Cerebrospinal Fluid and Further Tissue Samples for Biomarker Indicating Spinal Ischemia and Organ Failure in Patients With Thoracoabdominal Aortic Aneurysm
Status: UNKNOWN
Conditions: Thoracoabdominal Aortic Aneurysm
Interventions: DIAGNOSTIC_TEST: Determination of biomarker
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Cardiac Telerehabilitation Effectiveness Using Wearable Sensors
Status: UNKNOWN
Conditions: Cardiovascular Diseases|Cardiac Rehabilitation|Telerehabilitation
Interventions: OTHER: Telerehabilitation group|OTHER: Centre - based rehabilitation group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
Status: COMPLETED
Conditions: Hematologic Malignancies
Interventions: DRUG: Busulfan|DRUG: Fludarabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers
Status: COMPLETED
Conditions: Metastatic Breast Cancer|Metastatic Gastric Cancer
Interventions: DRUG: Trastuzumab for injection|DRUG: Herceptin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: BIOLOGICAL: Experimental: Tezepelumab|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms
Status: COMPLETED
Conditions: Hematopoietic and Lymphoid System Neoplasm|Malignant Breast Neoplasm|Malignant Head and Neck Neoplasm|Malignant Solid Neoplasm|Malignant Thoracic Neoplasm
Interventions: OTHER: Questionnaire Administration|BEHAVIORAL: Telephone-Based Intervention|OTHER: Virtual Technology Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effectiveness of Suprascapular Nerve Block in Arthroscopic Shoulder Surgery
Status: COMPLETED
Conditions: Rotator Cuff Tear|Pain
Interventions: PROCEDURE: Suprascapular nerve block|PROCEDURE: Interscalene nerve block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Status: RECRUITING
Conditions: Verruca Vulgaris|Warts|Common Wart
Interventions: DRUG: VDMN-21 Patch Low Dose|DRUG: VDMN-21 Patch High Dose|DRUG: Vehicle Patch
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial
Status: COMPLETED
Conditions: Alcohol Dependence
Interventions: DRUG: Ondansetron|DRUG: Olanzapine|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity
Status: COMPLETED
Conditions: Obesity
Interventions: OTHER: Exercise - caloric balance|OTHER: No Exercise - hyper-caloric diet|OTHER: No exercise - caloric balance
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: TMC435-TiDP16-C115 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Erythromycin and Between TMC435 and Darunavir/Ritonavir (DRV/r)
Status: COMPLETED
Conditions: Hepatitis C Virus
Interventions: DRUG: erythromycin|DRUG: Ritonavir|DRUG: TMC435|DRUG: Darunavir|DRUG: TMC435|DRUG: erythromycin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
Status: COMPLETED
Conditions: Glaucomas|Pterygium
Interventions: DEVICE: OculusGen Biodegradable Collagen Matrix Implant
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
Status: COMPLETED
Conditions: Postpartum Anemia Nos|Iron-deficiency
Interventions: DRUG: Iron Carboxymaltose|DRUG: Iron Isomaltoside|DRUG: Ferrous sulphate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Office Based Intervention to Reduce Bottle Use in Toddlers: TARGet Kids! Pragmatic Randomized Trial
Status: COMPLETED
Conditions: Educational Intervention and Toddler Bottle Use
Interventions: BEHAVIORAL: Educational Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: PREVENTION
Clinical trial: Randomizated Open-label Control Trial to Evaluate if the Incorporation of sFlt1/PlGF Ratio in the Diagnosis and Classification of PE Improves Maternal and Perinatal Outcomes in Women With the Suspicion of the Disease
Status: COMPLETED
Conditions: Preeclampsia
Interventions: DIAGNOSTIC_TEST: Placental biomarkers
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Assessing Dextenza Insert After SMILE Procedure
Status: COMPLETED
Conditions: Post Procedural Infection
Interventions: DRUG: Dexamethasone ophthalmic insert 0.4 mg|DRUG: Topical Prednisolone Acetate Ophthalmic Drops
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Flapless Esthetic Crown Lengthening for the Treatment of Excessive Gingival Display
Status: COMPLETED
Conditions: Gingival Overgrowth
Interventions: PROCEDURE: Open-flap|PROCEDURE: Flapless
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Status: COMPLETED
Conditions: Major Depressive Disorder (MDD)
Interventions: DRUG: Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cognitive Remediation for Cocaine Dependence
Status: COMPLETED
Conditions: Cocaine Dependence
Interventions: DRUG: levodopa/carbidopa|DRUG: Ropinirole 2 mg/d|DRUG: Placebo|DRUG: Ropinirole 4 mg/d
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Macronutrient Diet on Brain Activity
Status: COMPLETED
Conditions: Obesity
Interventions: BEHAVIORAL: Low carbohydrate diet|BEHAVIORAL: Moderate carbohydrate diet|BEHAVIORAL: High carbohydrate diet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
Status: UNKNOWN
Conditions: Non-Small Cell Lung Cancer
Interventions: DRUG: bevacizumab|DRUG: carboplatin|DRUG: gemcitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Beta-cryptoxanthin Supplement: Absorption and Function
Status: COMPLETED
Conditions: Beta-cryptoxanthin Supplementation
Interventions: DIETARY_SUPPLEMENT: Beta-cryptoxanthin (BCX)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Status: WITHDRAWN
Conditions: RLS
Interventions: DRUG: HORIZANT 300 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability Study of GSK1265744 Formulations
Status: COMPLETED
Conditions: Infections, Human Immunodeficiency Virus and Hepatitis
Interventions: DRUG: GSK1265744 Na Salt Tablets|DRUG: GSK1265744 Free Acid Nanomilled Capsules|DRUG: GSK1265744 Free Acid Micronized Capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Status: COMPLETED
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: exenatide|DRUG: taspoglutide|DRUG: taspoglutide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Stem Cells and Resynchronization Cardiac
Status: UNKNOWN
Conditions: Heart Failure
Interventions: PROCEDURE: Pacing and Stem Cells Implantations.|PROCEDURE: Pacing and Stem Cells Implantation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
Status: UNKNOWN
Conditions: Drug-naïve Patients With Parkinson's Disease|Apathy
Interventions: DRUG: AZILECT®|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Probiotics for Irritable Bowel Syndrome
Status: COMPLETED
Conditions: Irritable Bowel Syndrome
Interventions: DIETARY_SUPPLEMENT: Probiotics|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
Status: UNKNOWN
Conditions: Diabetic Retinopathy|Ranibizumab
Interventions: DRUG: Ranibizumab|PROCEDURE: No drug
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
Status: RECRUITING
Conditions: Hand, Foot and Mouth Disease|Herpangina
Interventions: BIOLOGICAL: low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated|BIOLOGICAL: medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated|BIOLOGICAL: high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated|BIOLOGICAL: Enterovirus type EV71 vaccine (Vero cell), Inactivated
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
Status: COMPLETED
Conditions: Thrombosis, Venous
Interventions: DRUG: Fondaparinux sodium|DRUG: unfractionated heparin (UFH)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
Status: COMPLETED
Conditions: Skin Irritation
Interventions: DRUG: Facial Moisturizer with SPF 50+
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals
Status: COMPLETED
Conditions: Cardiac Magnetic Resonance|T1 Mapping|Healthy Individuals
Interventions: OTHER: Fluid administration (Fresenius Kabi Sodium Chloride 0.9%)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Evaluation of the Results of Closed Kinetic Chain Exercises in Patellofemoral Pain Syndrome
Status: COMPLETED
Conditions: Exercise Training
Interventions: OTHER: Non-selective closed kinetic chain exercises (NSKCE) and selective closed kinetic chain exercises (SCKCE)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Transversus Abdominis Plane Block For Renal Transplant Recipients
Status: COMPLETED
Conditions: Disorder Related to Renal Transplantation|Pain
Interventions: PROCEDURE: TAP block|PROCEDURE: TAP block with placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Home Blood Pressure Study for Recent Stroke Survivors With High Blood Pressure *On Hold Due to Global Pandemic*
Status: UNKNOWN
Conditions: Ischemic Stroke|Hypertension
Interventions: DEVICE: Home Blood Pressure Monitoring Device (Qardio Arm)|OTHER: Primary Care Provider Blood Pressure Management
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effects of Early Sensory Reeducation Programs Using Mirror Therapy for Patients With Peripheral Nerve Injuries
Status: COMPLETED
Conditions: Sensation Disorders|Motor Deficit|Rehabilitation
Interventions: BEHAVIORAL: Sensorimotor reeducation programs
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: DRUG: FDL169|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: X-rays Trauma Request's by the Triage And Intake Nurse Intake and Referral Nurse:
Status: COMPLETED
Conditions: Limb Injury
Interventions: PROCEDURE: Radiography request by nurse|PROCEDURE: Radiography request by physician
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Use of Strattice Mesh in Paraesophageal Hernia Surgery
Status: COMPLETED
Conditions: Esophageal Hernia|Hernia, Esophageal|Hernia, Paraesophageal|Hiatal Hernia|Paraesophageal Hiatal Hernia|Sliding Esophageal Hernia|Sliding Hiatal Hernia
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: BIOLOGICAL: CAIV-T and TIV
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
Status: COMPLETED
Conditions: Cardiovascular Diseases|Depression|Heart Diseases|Myocardial Infarction|Angina, Unstable
Interventions: DRUG: Sertraline/omega-3|DRUG: Sertraline/Corn Oil
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome
Status: UNKNOWN
Conditions: Atrial Fibrillation
Interventions: DRUG: Losartan|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Treatment Of Shallow Periodontal Pockets Using PRF As an Adjunct To Scaling And Root Planing In Periodontitis Patients
Status: NOT_YET_RECRUITING
Conditions: Periodontitis
Interventions: OTHER: PRF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Feasibility of Parathyroidectomy With Exploration of 4 Parathyroid Glands in Outpatients
Status: UNKNOWN
Conditions: Primary Hyperparathyroidism
Interventions: PROCEDURE: outpatient management of parathyroidectomy|PROCEDURE: conventional management of parathyroidectomy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Feasibility, Acceptability, and Preliminary Effects of Lymfit
Status: COMPLETED
Conditions: Cancer Survivors|Lymphoma
Interventions: BEHAVIORAL: Lymfit Intervention|BEHAVIORAL: Wait-list control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY
Status: COMPLETED
Conditions: Myopia|Hyperopia
Interventions: DEVICE: narafilcon B daily disposable soft contact lenses|DEVICE: etafilcon A daily disposable soft contact lenses
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Acute Effects of HIIT and SSMIT on Intraocular Pressure Among Sedentary Individuals
Status: COMPLETED
Conditions: Intraocular Pressure
Interventions: OTHER: aerobic exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT
Status: UNKNOWN
Conditions: Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Interventions: DRUG: Tislelizumab|RADIATION: IMRT
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Status: COMPLETED
Conditions: End Stage Liver Disease|Hepatitis C
Interventions: DRUG: Daclizumub|DRUG: Tacrolimus|DRUG: Cyclosporine|DRUG: MMF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Status: RECRUITING
Conditions: Posttraumatic Headache|Mild Traumatic Brain Injury
Interventions: DRUG: Erenumab 140 Mg/mL Subcutaneous Solution|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
Status: COMPLETED
Conditions: Multiple Myeloma
Interventions: DRUG: Bortezomib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
Status: COMPLETED
Conditions: Prostate Adenocarcinoma|Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage III Prostate Cancer|Stage IV Prostate Cancer
Interventions: DRUG: Bicalutamide|DRUG: Flutamide|DRUG: Goserelin Acetate|DRUG: Ipilimumab|DRUG: Leuprolide Acetate|OTHER: Pharmacological Study
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Post-Operative Quality of Life Evaluation for Different Anesthesia Techniques for Arthroscopic Shoulder Surgery
Status: COMPLETED
Conditions: Rotator Cuff Injury
Interventions: DEVICE: Baxter INFUSOR System|DRUG: Single Injection of Local Anesthetic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
Status: COMPLETED
Conditions: Aortic Stenosis|Symptomatic Aortic Stenosis|Aortic Regurgitation
Interventions: DEVICE: SAPIEN XT THV with the NovaFlex+ delivery system
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Chemotherapy for Resectable Colorectal Liver Metastases
Status: COMPLETED
Conditions: Metastatic Colorectal Cancer|Metastatic Liver Cancer
Interventions: OTHER: Liver resection and Neoadjuvant chemotherapy|OTHER: Liver resection and Adjuvant chemotherapy|OTHER: Liver resection, Neoadjuvant chemotherapy and Adjuvant chemotherapy|PROCEDURE: Liver resection
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Status: WITHDRAWN
Conditions: Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis
Interventions: DRUG: No intervention
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?
Status: COMPLETED
Conditions: Invasive Pneumococcal Disease, Recurrent Isolated, 1|Invasive Pneumococcal Disease, Recurrent Isolated, 2|Invasive Pneumococcal Disease, Protection Against|Primary Immunodeficiency
Interventions: OTHER: Referral to Immunology
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient
Status: UNKNOWN
Conditions: Gastric Cancer|Gastrectomy|Malnutrition
Interventions: DRUG: Parenteral Nutrition Solutions
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Short and Medium-term Effects of Manual Therapy on Latent Myofascial Pain
Status: COMPLETED
Conditions: Latent Myofascial Trigger Point of Upper Trapezius Muscle
Interventions: OTHER: Muscle energy technique|OTHER: Passive stretching technique|OTHER: Ischemic compression technique|OTHER: Sham technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT